Patrícia Moreira Gomes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Patrícia Moreira Gomes has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Carmen Lisboa
3 shared publicationsAna Pedrosa
2 shared publications- Bárbara Vieira Granja
Department of Dermatology and Venereology Sao Joao Local Health Unit (ULS) Porto Portugal
2 shared publications Filomena Azevedo
Department of Dermatology and Venereology
2 shared publicationsRuben Costa
2 shared publications- Ana Margarida Monteiro
Endocrinology Department, Hospital de Braga, Braga, Portugal
1 shared publication
Latest Publications
- Open Access
- 31 August 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (5)
Successful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- 31 August 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 101 (5)
Open AccessSuccessful treatment of coexisting alopecia areata and hidradenitis suppurativa with upadacitinib
- Open Access
- 1 July 2026
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106
Real-world Outcomes of Adalimumab in Hidradenitis Suppurativa: A 10-year Retrospective Longitudinal Study
- 1 July 2026
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106
Open AccessReal-world Outcomes of Adalimumab in Hidradenitis Suppurativa: A 10-year Retrospective Longitudinal Study
- Open Access
- 26 March 2026
- Published by Instituto Mexicano del Seguro Social in Portuguese Journal of Dermatology and Venereology
- Vol. 84 (1)
A giant inguinal dermatofibrosarcoma protuberans
- 26 March 2026
- Published by Instituto Mexicano del Seguro Social in Portuguese Journal of Dermatology and Venereology
- Vol. 84 (1)
Open AccessA giant inguinal dermatofibrosarcoma protuberans
- Open Access
- 18 March 2026
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 117 (7) , 104626
Primary Umbilical Endometriosis
- 18 March 2026
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 117 (7) , 104626
Open AccessPrimary Umbilical Endometriosis
- Open Access
- 1 January 2026
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 70 (4) , 01-08
Diagnostic criteria for gestational hyperglycemia in women from a public maternity hospital in Brazil
Objective: This study aimed to determine the prevalence of hyperglycemia using different diagnostic criteria for gestational diabetes mellitus. Subjects and methods: This cross-sectional study evaluated parturients attending a hospital complex from January to December 2017. Data were obtained retrospectively from medical records. Fasting glucose and 75-g oral glucose tolerance test results were used to assess the prevalence of hyperglycemia during pregnancy. The diagnostic criteria evaluated were: 1998 World Health Organization (WHO98), 2003 American Diabetes Association (ADA03), 2015 National Institute [...] Abstract Objective: This study aimed to determine the prevalence of hyperglycemia using different diagnostic criteria for gestational diabetes mellitus. Subjects and methods: This cross-sectional study evaluated parturients attending a hospital complex from January to December 2017. Data were obtained retrospectively from medical records. Fasting glucose and 75-g oral glucose tolerance test results were used to assess the prevalence of hyperglycemia during pregnancy. The diagnostic criteria evaluated were: 1998 World Health Organization (WHO98), 2003 American Diabetes Association (ADA03), 2015 National Institute
- 1 January 2026
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 70 (4) , 01-08
Open AccessDiagnostic criteria for gestational hyperglycemia in women from a public maternity hospital in Brazil
Objective: This study aimed to determine the prevalence of hyperglycemia using different diagnostic criteria for gestational diabetes mellitus. Subjects and methods: This cross-sectional study evaluated parturients attending a hospital complex from January to December 2017. Data were obtained retrospectively from medical records. Fasting glucose and 75-g oral glucose tolerance test results were used to assess the prevalence of hyperglycemia during pregnancy. The diagnostic criteria evaluated were: 1998 World Health Organization (WHO98), 2003 American Diabetes Association (ADA03), 2015 National Institute [...] Abstract Objective: This study aimed to determine the prevalence of hyperglycemia using different diagnostic criteria for gestational diabetes mellitus. Subjects and methods: This cross-sectional study evaluated parturients attending a hospital complex from January to December 2017. Data were obtained retrospectively from medical records. Fasting glucose and 75-g oral glucose tolerance test results were used to assess the prevalence of hyperglycemia during pregnancy. The diagnostic criteria evaluated were: 1998 World Health Organization (WHO98), 2003 American Diabetes Association (ADA03), 2015 National Institute
- 13 January 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (9) , 1680-1681
VEXAS Syndrome: An Unusual Dermatological Presentation With Histiocytic Infiltration
- 13 January 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 64 (9) , 1680-1681
VEXAS Syndrome: An Unusual Dermatological Presentation With Histiocytic Infiltration
- Open Access
- 26 September 2024
- Published by Instituto Mexicano del Seguro Social in Portuguese Journal of Dermatology and Venereology
- Vol. 82 (3) , 156-166
Polycystic ovary syndrome: a dermatologic approach
Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies in women of reproductive age. It is a multifactorial disease with endocrinological, genetic, and environmental factors playing a role in its pathophysiology. The main diagnostic criteria include the presence of hyperandrogenism, chronic anovulation, and polycystic ovaries on ultrasound. Women with PCOS present a variety of signs and symptoms, as well as an increased risk of metabolic, cardiovascular, and reproductive disorders. This syndrome has an important psychological impact, and it is associated with a decreased quality of life. The dermatological manifestations, due to hyperandrogenism, include hirsutism, acne, and androgenetic alopecia. These manifestations provide clues for PCOS diagnosis, and early treatment is essential to improve the quality of life and well-being of patients. Thus, as part of a multidisciplinary approach, dermatologists play an essential role in the diagnosis and treatment of women with PCOS. Treatment includes hormonal therapy to control hyperandrogenism and non-hormonal therapy for each dermatological manifestation.
- 26 September 2024
- Published by Instituto Mexicano del Seguro Social in Portuguese Journal of Dermatology and Venereology
- Vol. 82 (3) , 156-166
Open AccessPolycystic ovary syndrome: a dermatologic approach
Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies in women of reproductive age. It is a multifactorial disease with endocrinological, genetic, and environmental factors playing a role in its pathophysiology. The main diagnostic criteria include the presence of hyperandrogenism, chronic anovulation, and polycystic ovaries on ultrasound. Women with PCOS present a variety of signs and symptoms, as well as an increased risk of metabolic, cardiovascular, and reproductive disorders. This syndrome has an important psychological impact, and it is associated with a decreased quality of life. The dermatological manifestations, due to hyperandrogenism, include hirsutism, acne, and androgenetic alopecia. These manifestations provide clues for PCOS diagnosis, and early treatment is essential to improve the quality of life and well-being of patients. Thus, as part of a multidisciplinary approach, dermatologists play an essential role in the diagnosis and treatment of women with PCOS. Treatment includes hormonal therapy to control hyperandrogenism and non-hormonal therapy for each dermatological manifestation.
- 14 March 2022
- Published by Springer Nature in Hormones
- Vol. 21 (2) , 287-293
Postpartum reclassification test in gestational diabetes: can the test be reduced to 1 hour?
Purpose In gestational diabetes mellitus (GDM), a postpartum oral glucose tolerance test (OGTT) is recommended. However, poor adherence to this procedure has been described, and the time required is one of the reasons. Our aims were to identify predictive factors for abnormal 2-h reclassification OGTT values, including OGTT 1-h glucose, and, if it was a factor, to determine the 1-h cutoff point that best identifies abnormal values at 2 h. Methods This was a retrospective study of 769 patients diagnosed with GDM between 2014 and 2019 in a tertiary center. The sample was divided into two groups according to the presence/absence of abnormal 2-h reclassification values, and predictive factors were studied. To determine the 1-h glycemia cutoff point capable of identifying 2-h changes, a ROC curve was drawn and the Youden index was used. Results The mean age of included women was 33.6 ± 4.95 years: 70 of them (9.1%) had an abnormal 2-h test result. Women with a history of GDM (OR = 3.41, p = .012) and higher 1-h glycemia value (OR = 1.05, p < .001) had a higher risk of developing an abnormal 2-h test result. One-hour glycemia ≥ 142 mg/dL had a sensitivity of 91.4% and specificity of 75.1% to identify changes in the test at 2 h; area under the curve to predict 2-h changes was 0.90 (CI 95%: 0.86 – 0.93). Conclusion Glucose measurement at 1 h predicts alterations at 2 h in the reclassification test with excellent diagnostic accuracy, and the cutoff point of ≥ 142 mg/dL presents high sensitivity. These findings could serve as a foundation for a possible future redefinition of the OGTT procedure, but further investigation is required.
- 14 March 2022
- Published by Springer Nature in Hormones
- Vol. 21 (2) , 287-293
Postpartum reclassification test in gestational diabetes: can the test be reduced to 1 hour?
Purpose In gestational diabetes mellitus (GDM), a postpartum oral glucose tolerance test (OGTT) is recommended. However, poor adherence to this procedure has been described, and the time required is one of the reasons. Our aims were to identify predictive factors for abnormal 2-h reclassification OGTT values, including OGTT 1-h glucose, and, if it was a factor, to determine the 1-h cutoff point that best identifies abnormal values at 2 h. Methods This was a retrospective study of 769 patients diagnosed with GDM between 2014 and 2019 in a tertiary center. The sample was divided into two groups according to the presence/absence of abnormal 2-h reclassification values, and predictive factors were studied. To determine the 1-h glycemia cutoff point capable of identifying 2-h changes, a ROC curve was drawn and the Youden index was used. Results The mean age of included women was 33.6 ± 4.95 years: 70 of them (9.1%) had an abnormal 2-h test result. Women with a history of GDM (OR = 3.41, p = .012) and higher 1-h glycemia value (OR = 1.05, p < .001) had a higher risk of developing an abnormal 2-h test result. One-hour glycemia ≥ 142 mg/dL had a sensitivity of 91.4% and specificity of 75.1% to identify changes in the test at 2 h; area under the curve to predict 2-h changes was 0.90 (CI 95%: 0.86 – 0.93). Conclusion Glucose measurement at 1 h predicts alterations at 2 h in the reclassification test with excellent diagnostic accuracy, and the cutoff point of ≥ 142 mg/dL presents high sensitivity. These findings could serve as a foundation for a possible future redefinition of the OGTT procedure, but further investigation is required.